reference/27374379

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27374379

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	662
issn	1096-911X 0098-1532
issueIdentifier	6
pageRange	659-662
publicationName	Medical and Pediatric Oncology
startingPage	659
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3cceacda18de6365f4455b5a250c8518 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9398e637563d71237dbee4a1a1858b1d
bibliographicCitation	Anderson CP, Keshelava N, Satake N, Meek WH, Reynolds CP. Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression. Med Pediatr Oncol. 2000 Dec;35(6):659–62. doi: 10.1002/1096-911x(20001201)35:6<659::aid-mpo38>3.0.co;2-4. PMID: 11107141.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b127662126b4fea974896d53ff080af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00aeeaf785fe8cc660212d5e692fd406 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cb9e2836c090dd0845edc2ac4e945c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d15c06e3f5353bd789b21c193102875 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2827-8536 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9fe762b7a99c1016c8094c5b84d57a6
date	200012
identifier	https://pubmed.ncbi.nlm.nih.gov/11107141 https://doi.org/10.1002/1096-911x%2820001201%2935:6%3C659::aid-mpo38%3E3.0.co%3B2-4
isPartOf	https://portal.issn.org/resource/ISSN/1096-911X https://portal.issn.org/resource/ISSN/0098-1532 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5644
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression
discusses	http://id.nlm.nih.gov/mesh/M0028777 http://id.nlm.nih.gov/mesh/M0013330 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0028268
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009447Q000473 http://id.nlm.nih.gov/mesh/D000964Q000627 http://id.nlm.nih.gov/mesh/D008558Q000627 http://id.nlm.nih.gov/mesh/D009447Q000188 http://id.nlm.nih.gov/mesh/D018906Q000627 http://id.nlm.nih.gov/mesh/D019328Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D014407
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8646 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21157 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886

Showing number of triples: 1 to 52 of 52.